| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |